NEW YORK — Tasso has struck a deal to offer its blood-collection devices in Japan through a new joint venture with Tokyo-based drug development services provider Shin Nippon Biomedical Laboratories, ...

The company presented its results this week at a conference and anticipates that with additional validation early next year, it will be ready to file for regulatory approval.

NEW YORK – Invivoscribe announced Thursday that its test for FLT3 mutations in patients with leukemia has achieved regulatory compliance in the UK and Switzerland.

The company will use the money to advance the development and commercialization of its liquid biopsy cancer detection panels.

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

Proceeds from the offering will be used for research and continued product development, clinical studies, and product commercialization.

Justin Hanson operated a kickback scheme in which he paid the owner of a Milwaukee substance abuse treatment clinic kickbacks for urine drug testing referrals.